US Patent

US10806792 — Itraconazole compositions and dosage forms, and methods of using the same

Formulation · Assigned to Mayne Pharma International Pty Ltd · Expires 2033-06-21 · 7y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions, including solid oral dosage forms, containing itraconazole for treating fungal infections.

USPTO Abstract

The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.

Drugs covered by this patent

Patent Metadata

Patent number
US10806792
Jurisdiction
US
Classification
Formulation
Expires
2033-06-21
Drug substance claim
No
Drug product claim
Yes
Assignee
Mayne Pharma International Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.